Molecular subtyping of ependymoma and prognostic impact of Ki-67
In this study, we propose a cost-effective schematic diagnostic flow of EPNs by the anatomical location, three biomarkers (L1CAM, H3K27me3, and EZHIP), and a cut-off of a 7% Ki-67 labeling index.
Source: Brain Tumor Pathology - Category: Neurology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Ependymoma | Genetics | Neurology | Pathology | Study